|
|
| PR8011c | 前列腺疾病谱组织芯片，附gleason分级、gleason评分、TNM和临床分期，80例/80点，替代PR8011b | | 点 数 | 80 | 例 数 | 80 | | 行 数 | 8 | 列 数 | 10 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
Pro -Prostate Lym -Lymph node Cos -Costal bone |
Hyperplasi Inflammati Malignant (I) Malignant (IIA) Malignant (III) Malignant (IV) Metastasis NAT Normal |
|
|
TISSUE ARRAYS PR8011c |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
A | | | | | | | | | | | |
B | | | | | | | | | | | |
C | | | | | | | | | | | |
D | | | | | | | | | | | |
E | | | | | | | | | | | |
F | | | | | | | | | | | |
G | | | | | | | | | | | |
H | | | | | | | | | | | |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Gleason Grade | Gleason Score |
| A1 | 1 | 71 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 2 | 1+2 |
| A2 | 2 | 74 | M | Prostate | Adenocarcinoma | | T4N1M0 | IV | Malignant | 2 | 1+2 |
| A3 | 3 | 71 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3 | 3+3 |
| A4 | 4 | 71 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3 | 2+3 |
| A5 | 5 | 69 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 3 | 3+3 |
| A6 | 6 | 75 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3 | 3+3 |
| A7 | 7 | 71 | M | Prostate | Adenocarcinoma | | T1N0M0 | I | Malignant | 3 | 3+3 |
| A8 | 8 | 76 | M | Prostate | Adenocarcinoma | | T2AN0M0 | IIA | Malignant | 3 | 3+4 |
| A9 | 9 | 82 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3 | 4+3 |
| A10 | 10 | 74 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3 | 3+4 |
| B1 | 11 | 73 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 3 | 3+4 |
| B2 | 12 | 62 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 3 | 3+5 |
| B3 | 13 | 81 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 3 | 3+3 |
| B4 | 14 | 64 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 4 | 4+5 |
| B5 | 15 | 68 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3--4 | 3+4 |
| B6 | 16 | 70 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 4 | 4+5 |
| B7 | 17 | 80 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 4 | 4+5 |
| B8 | 18 | 72 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 4 | 4+5 |
| B9 | 19 | 75 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 4 | 4+5 |
| B10 | 20 | 57 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 3 | 4+3 |
| C1 | 21 | 78 | M | Prostate | Adenocarcinoma | | T4N1M0 | IV | Malignant | 4 | 4+5 |
| C2 | 22 | 56 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 4 | 4+5 |
| C3 | 23 | 82 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 5 | 5+5 |
| C4 | 24 | 20 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 4 | 4+5 |
| C5 | 25 | 72 | M | Prostate | Adenocarcinoma | | T2N0M1 | IV | Malignant | 4 | 4+5 |
| C6 | 26 | 62 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 4 | 4+5 |
| C7 | 27 | 82 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 5 | 5+5 |
| C8 | 28 | 60 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 5 | 5+5 |
| C9 | 29 | 87 | M | Prostate | Adenocarcinoma | | T2N0M0 | IIA | Malignant | 5 | 5+5 |
| C10 | 30 | 76 | M | Prostate | Adenocarcinoma | | T3N0M0 | III | Malignant | 5 | 5+5 |
| D1 | 31 | 69 | M | Prostate | Small acinous carcinoma | | T2N0M0 | IIA | Malignant | 3 | 2+3 |
| D2 | 32 | 70 | M | Prostate | Small acinous carcinoma | | T2N0M0 | IIA | Malignant | 5 | 5+4 |
| D3 | 33 | 63 | M | Costal bone | Metastatic adenocarcinoma from prostate | | - | - | Metastasis | - | - |
| D4 | 34 | 62 | M | Lymph node | Metastatic adenocarcinoma from prostate | | - | - | Metastasis | - | - |
| D5 | 35 | 78 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| D6 | 36 | 67 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| D7 | 37 | 66 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| D8 | 38 | 72 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| D9 | 39 | 84 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| D10 | 40 | 56 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E1 | 41 | 72 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E2 | 42 | 65 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E3 | 43 | 69 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E4 | 44 | 73 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E5 | 45 | 66 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E6 | 46 | 56 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E7 | 47 | 69 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E8 | 48 | 60 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E9 | 49 | 70 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| E10 | 50 | 64 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F1 | 51 | 72 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F2 | 52 | 65 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F3 | 53 | 69 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F4 | 54 | 74 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F5 | 55 | 67 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F6 | 56 | 69 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F7 | 57 | 26 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F8 | 58 | 73 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F9 | 59 | 72 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| F10 | 60 | 71 | M | Prostate | Hyperplasia | | - | - | Hyperplasi | - | - |
| G1 | 61 | 68 | M | Prostate | Chronic inflammation | | - | - | Inflammati | - | - |
| G2 | 62 | 69 | M | Prostate | Chronic inflammation | | - | - | Inflammati | - | - |
| G3 | 63 | 27 | M | Prostate | Chronic inflammation | | - | - | Inflammati | - | - |
| G4 | 64 | 71 | M | Prostate | Chronic inflammation | | - | - | Inflammati | - | - |
| G5 | 65 | 68 | M | Prostate | Chronic inflammation | | - | - | Inflammati | - | - |
| G6 | 66 | 78 | M | Prostate | Chronic inflammation | | - | - | Inflammati | - | - |
| G7 | 67 | 21 | M | Prostate | Adjacent normal prostate tissue | | - | - | NAT | - | - |
| G8 | 68 | 35 | M | Prostate | Adjacent normal prostate tissue | | - | - | NAT | - | - |
| G9 | 69 | 41 | M | Prostate | Adjacent normal prostate tissue | | - | - | NAT | - | - |
| G10 | 70 | 64 | M | Prostate | Adjacent normal prostate tissue | | - | - | NAT | - | - |
| H1 | 71 | 77 | M | Prostate | Adjacent normal prostate tissue | | - | - | NAT | - | - |
| H2 | 72 | 80 | M | Prostate | Adjacent normal prostate tissue | | - | - | NAT | - | - |
| H3 | 73 | 29 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H4 | 74 | 37 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H5 | 75 | 35 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H6 | 76 | 20 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H7 | 77 | 35 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H8 | 78 | 43 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H9 | 79 | 33 | M | Prostate | Prostate tissue | | - | - | Normal | - | - |
| H10 | 80 | 45 | M | Prostate | Prostate tissue | | - | - | Normal | - | - | | Tissue Marker |
|
